These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6689401)

  • 1. [Pharmacokinetic study of piroxicam following oral and rectal administration].
    Acerbi D; Daccò L; Palummeri E
    Boll Chim Farm; 1983 Sep; 122(9):19S-27S. PubMed ID: 6689401
    [No Abstract]   [Full Text] [Related]  

  • 2. Piroxicam capsules versus suppositories: a pharmacokinetic and clinical trial.
    Aärynen M; Palho J
    Arzneimittelforschung; 1986 Apr; 36(4):744-7. PubMed ID: 3521618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic study of piroxicam in healthy man after administration of a single dose equal to 20 mg, by the oral route].
    Fourtillan JB; Dubourg D
    Therapie; 1983; 38(2):163-70. PubMed ID: 6636023
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of isoxicam in two pharmaceutical formulations.
    Gras J; Perez MC; Fernandez E; Gelpi E
    Boll Chim Farm; 1985 May; 124(5):190-5. PubMed ID: 4052240
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of isoxicam in man following oral administration.
    Kölle EU; Hengy H; Vollmer KO
    Arzneimittelforschung; 1983; 33(4):582-6. PubMed ID: 6683539
    [No Abstract]   [Full Text] [Related]  

  • 6. Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route. Comparison with oral indometacin and phenylbutazone.
    Schiantarelli P; Cadel S
    Arzneimittelforschung; 1981; 31(1):87-92. PubMed ID: 6971112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of a new non-steroid anti-inflammatory agent for rectal administration].
    Cervellin GF; Mancini M; Pedrazzoni M; Franchi F
    G Clin Med; 1982 Jan; 63(1):37-50. PubMed ID: 7106457
    [No Abstract]   [Full Text] [Related]  

  • 8. [Piroxicam (Felden), in the form of 20 mg suppositories, in the treatment of acute and chronic rheumatic diseases].
    Chantraine A; Van Ouwenaller C; Hinz G
    Rev Med Suisse Romande; 1984 Apr; 104(4):303-8. PubMed ID: 6610909
    [No Abstract]   [Full Text] [Related]  

  • 9. Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in man.
    Schiantarelli P; Acerbi D; Bovis G
    Arzneimittelforschung; 1981; 31(1):92-7. PubMed ID: 6971114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biopharmaceutic and pharmacokinetic studies on piroxicam suppositories].
    Chen XL; Xi NZ; Wang XJ; Ge SD
    Zhongguo Yao Li Xue Bao; 1986 Nov; 7(6):560-3. PubMed ID: 2955649
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiinflammatory activity and bioavailability of percutaneous piroxicam.
    Schiantarelli P; Cadel S; Acerbi D; Pavesi L
    Arzneimittelforschung; 1982; 32(3):230-5. PubMed ID: 7200781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inter- and intra-individual variations on the disposition of piroxicam. Pharmacokinetics in healthy man and the patient with renal insufficiency].
    Dupont D; Dayer P; Balant L; Gorgia A; Fabre J
    Pharm Acta Helv; 1982; 57(1):20-6. PubMed ID: 7058201
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of allopurinol oral and rectal dosage forms.
    Chang SL; Kramer WG; Feldman S; Ballentine R; Frankel LS
    Am J Hosp Pharm; 1981 Mar; 38(3):365-8. PubMed ID: 7223751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of ampiroxicam, a prodrug of piroxicam, in man.
    Falkner FC; Twomey TM; Borgers AP; Garg D; Weidler D; Gerber N; Browder IW
    Xenobiotica; 1990 Jun; 20(6):645-52. PubMed ID: 2219958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of piroxicam in man.
    Hobbs DC
    Eur J Rheumatol Inflamm; 1983; 6(1):46-55. PubMed ID: 6861813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioavailability of codeine and paracetamol in a combination preparation following oral and rectal administration].
    Kummer M; Mehlhaus N
    Fortschr Med; 1984 Feb; 102(7):173-8. PubMed ID: 6706275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piroxicam suppositories for the treatment of acute and chronic rheumatic diseases.
    Van Ouwenaller C; Chantraine A
    Clin Rheumatol; 1985 Mar; 4(1):98-100. PubMed ID: 3987206
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans.
    Ramakrishna S; Fadnavis NW; Diwan PV
    Arzneimittelforschung; 1996 Feb; 46(2):175-7. PubMed ID: 8720309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The topical anti-inflammatory effects of piroxicam in rodents.
    Larson DL; Lombardino JG
    Agents Actions; 1980 Jun; 10(3):246-51. PubMed ID: 7405751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.